Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
07/2010
07/29/2010US20100190728 Synthesis Of Metabolically Stable Analgesics, Pain Medications And Other Agents
07/29/2010US20100187984 Materials with aza-dibenzothiophene or aza-dibenzofuran core for pholed
07/29/2010CA2750777A1 Bicyclic heterocyclic spiro compounds
07/29/2010CA2749217A1 Compositions and methods for inhibition of the jak pathway
07/28/2010EP2210892A2 Neurologically-active compounds
07/28/2010EP2209790A2 Equilibrative nucleoside transporter ent1 inhibitors
07/28/2010EP1551844B1 Antitumoral analogs of lamellarins
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
07/28/2010CN1788000B Phthalazinone derivatives
07/28/2010CN101787029A Long-chain alkyl coptisine halate derivative, synthesis method and application
07/28/2010CN101787028A Method for extracting galanthamine from lycoris aurea
07/27/2010US7763725 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists and antagonists of melanocortin receptors
07/27/2010US7763623 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
07/27/2010US7763622 such as 5-methyl-6-(2-chloro-4-fluorophenyl)-7-(4-methylpiperidin-1-yl)-[1,2,4]-triazolo[1,5-a]pyrimidine, used for controlling phytopathogenic fungi; improved fungicidal activity
07/27/2010US7763615 derivatives of ecteinascidins, particularly ecteinascidin 736, used for the treatment of lung, colon, kidney, prostate, cervical, ovarian, breast or pancreatic cancer, leukaemia or melanoma in mammals; reduced systemic toxicity and improved pharmacokinetics
07/22/2010WO2010083384A2 Non-peptidyl, potent, and selective mu opioid receptor antagonists
07/22/2010WO2010083359A2 New materials with aza-dibenzothiophene or aza-dibenzofuran core for pholed
07/22/2010WO2010082554A1 Novel compound, polymerizable composition, color filter and process for produciton thereof, solid-state imaging element, and lithographic printing original plate
07/22/2010US20100184985 Process for the production of macrolides using a novel strain, streptomyces sp. bicc 7522
07/22/2010US20100184796 Agonists of bitter taste receptors and uses thereof
07/22/2010US20100184759 Pyrano-pyrazole-amines
07/22/2010US20100184751 Heterocyclic compounds for the treatment of tuberculosis
07/22/2010US20100184745 Use of parthenolide derivatives as antileukemic and cytotoxic agents
07/21/2010CN101784546A Tricyclic heterocyclic compounds as gaba a modulators
07/21/2010CN101781365A Artificial antigen of tetraodotoxin and corresponding specific antibody and preparation method and application thereof
07/21/2010CN101781312A Method for synthesizing derivatives of quinoline or indole
07/21/2010CN101781307A Method for separating and purifying coptisine monomers
07/21/2010CN101781306A Ion-pair compounds of sanguinarine from Chinese herbs extract, and preparation and applications thereof
07/21/2010CN101781305A Method for artificially synthesizing galanthamine
07/21/2010CN101781304A Tetrahydroisoquinoline compound and preparation method and application thereof
07/21/2010CN101780082A Use of imidazole alkaloids as anti-Infective medicament synergists and medicinal composition containing anti-Infective medicament synergists
07/20/2010US7759498 such as 11-(2-dimethylamino-ethyl)-6,11-dihydro-5-thia-11-aza-benzo[a]fluoren-8-ol and 11-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-6,11-dihydro-5-thia-11-aza-benzo [a]fluoren-8-ol; selective estrogen and androgen receptor modulators
07/20/2010US7759373 nitrogen-containing 5-membered heterocyclic compound
07/20/2010US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor
07/20/2010US7759361 treating a cancer, autoimmune diseases and cardiovscular disorders comprising administering drugs such as Isobutyric acid 2-isobutyryloxymethyl-3-oxo-1-aza-bicyclo[2.2.2]oct-ylmethyl ester; antiproliferative agents
07/20/2010US7759356 administering adenosine receptors antagonists, such as 2-amino-4-phenyl-indeno[1,2-d]pyrimidin-5-one, for the treatment of neurodegenerative diseases; Parkinson's Disease
07/15/2010WO2010081034A2 Fluorine containing compounds and methods of use thereof
07/15/2010WO2010080817A2 Carbohydrate-cyclopamine conjugates as anticancer agents
07/15/2010WO2010079114A1 Time temperature indicator comprising indolenin based spiropyrans
07/15/2010WO2010079098A1 Preparation of a photochromic ink
07/15/2010US20100179190 Bicyclic pyrazolo protein kinase modulators
07/15/2010US20100179180 Crystalline irinotecan hydrochloride and methods for its preparation
07/15/2010CA2749315A1 Fluorine containing compounds and methods of use thereof
07/14/2010EP2205605A1 Hydrated crystalline esters of camptothecin for the treatment of cancer
07/14/2010EP2205592A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/14/2010EP2205576A1 Benzothiazoles as ghrelin receptor modulators
07/14/2010EP1966218B1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases
07/14/2010EP1687312B1 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof
07/14/2010CN101775022A Ion-pair compound of chelerythrine from Chinese medicine extracts, preparation and application thereof
07/14/2010CN101775021A Method for selective synthesis of alpha-narcotine with participation of blockage group
07/14/2010CN101775020A Poly-substituted chromone pyrrole compound and synthetic method and application thereof
07/14/2010CN101774938A Type of capsaicine derivative, preparation method thereof and medical use thereof
07/13/2010US7754733 specific crystalline polymorphic form of the pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride (or 9-dimethylaminomethyl-10-hydroxycamptothecin monohydrochloride pentahydrate)
07/13/2010US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders
07/13/2010US7754730 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
07/13/2010US7754718 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/13/2010CA2352066C Process for the preparation of derivatized polymers
07/08/2010WO2010078307A1 Spiro-oxindole-derivatives as sodium channel blockers
07/08/2010WO2010077839A1 Substituted oxindol cb2 agonists for pain treatment
07/08/2010WO2010077530A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
07/08/2010WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010WO2010045551A8 Xanthenone-4-acetic acid derivatives
07/08/2010US20100173824 Azepinoindole Derivatives As Pharmaceutical Agents
07/08/2010US20100173778 3-Biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
07/08/2010CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010CA2745071A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
07/07/2010EP2204398A1 Camptothecin polymer derivative and uses of the same
07/07/2010EP2203454A1 Tricyclic heterocyclic derivatives
07/07/2010EP2203445A1 Azabicyclo ý3. 1. o¨hexyl derivatives as modulators of dopamine d3 receptors
07/07/2010EP1940817B1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
07/07/2010EP1765829B1 Tricyclic compounds and their use as mglur1 antagonists
07/07/2010EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents
07/07/2010CN101772503A Oxaspirocyclic spiro-substituted tetramic and tetronic acid derivatives
07/07/2010CN101768173A Norcantharidin dimer derivate as well as synthetic method and application thereof
07/07/2010CN101768164A Naloxone hydrochloride compound with high purity
07/07/2010CN101768163A Method for separating purified nitidine chloride by using cation exchange resin
07/07/2010CN101768159A Method for synchronously separating tetrahydropalmatine and fumarine from fumitory
07/06/2010US7750556 Triazole derivatives and use thereof in organic light-emitting diodes (OLEDs)
07/06/2010US7750167 Through a stilbene derivative, to a pyrrolidine intermediate such as N-methyl-2-(2-bromophenyl)-3-(2-hydroxy-5-chlorophenyl)-pyrrolidine, followed by cyclization; asenapine is an antipsychotic agent; industrial scale
07/06/2010US7750037 Antidepressant
07/06/2010US7750034 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
07/06/2010US7750017 Anticancer agents; hyperproliferative diseases; 4-(phenylamino)benzothieno[2,3-d]pyrimidines; inhibit the tyrosine kinase activities of EGFR (erbB1) and HER2
07/06/2010US7750015 Nitrogen-containing heterocyclic compounds and methods of use thereof
07/06/2010US7750009 7-benzyloxy-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine, uitable for treating respiratory system or gastrointestinal disorders, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system and cancers
07/06/2010US7750008 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis
07/06/2010US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
07/01/2010WO2010075069A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
07/01/2010WO2010011748A3 Synthetic intermediates and processes
07/01/2010US20100168426 Novel processes for the production of useful intermediates
07/01/2010US20100168160 Genipin Derivatives and Uses Thereof
07/01/2010US20100168154 1-substituted tetrahydroisoquinoline compound
07/01/2010US20100168151 Novel processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-c]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of pde iv inhibitors
07/01/2010US20100168129 Drugs with anticholestatic activity
07/01/2010US20100168098 Viral Polymerase Inhibitors
07/01/2010US20100168080 Novel compounds useful as cc chemokine receptor ligands
06/2010
06/30/2010EP2200997A1 Synthesis of deuterated catechols and benzoýd¨ý1,3¨dioxoles and derivatives thereof
06/30/2010EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
06/30/2010EP2200436A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 298